4Nakatani M,Takeyama Y,Shibata M,et al.Mechanisms of restenosis after coronary intervention.Difference between plain old balloon angioplasty and stenting[J].Cardiovasc Pathl,2003,12:40-48.
5Mintz GS,Shah VM,Weissman NJ,et al.Regional remodeling as the cause of late stent malapposition[J].Circulation,2003,107:2660.
6Andrew R.Sirolimus for the prevention of in-stent restenosis in a coronaryartery[J].Circulation,2003,349:1307-1313.
7Tee AR,Manning BD,Roux PP,et al.Tuberous sclerosis complex gene products,Tuberin and Hamartin,control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb[J].Curr Biol,2003,13(15):1259-1268.
8Sousa JE,Costa MA,Sousa AG,et al.Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries[J].Circulation,2003,107:381-383.
9Degertekin M,Regar E,Tanabe K,et al.Sirolimus-eluting stent for treatment of complex in-stent restenosis.The first clinical experience[J].J Am Coll Cardiol,2003,41(2):184-189.
10Sousa JE,Costa MA,Abizaid A,et al.Sirolimus-eluting stent for the treatment of in-stent restenosis:a quantitative coronary angiography and three-dimensional intravascular ultrasound study[J].Circulation,2003,107(1):24-27.
